Heramed Ltd (AU:HMD) — Market Cap & Net Worth
Market Cap & Net Worth: Heramed Ltd (HMD)
Heramed Ltd (AU:HMD) has a market capitalization of $38.61 Million (AU$54.57 Million) as of May 3, 2026. Listed on the AU stock exchange, this Australia-based company holds position #22808 globally and #873 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Heramed Ltd's stock price AU$0.05 by its total outstanding shares 1113653427 (1.11 Billion). Analyse cash flow conversion of Heramed Ltd to see how efficiently the company converts income to cash.
Heramed Ltd Market Cap History: 2018 to 2026
Heramed Ltd's market capitalization history from 2018 to 2026. Data shows change from $126.08 Million to $38.61 Million (-16.15% CAGR).
Heramed Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Heramed Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
69.89x
Heramed Ltd's market cap is 69.89 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $126.08 Million | $59.67K | -$2.91 Million | 2112.79x | N/A |
| 2019 | $126.08 Million | $147.14K | -$3.17 Million | 856.84x | N/A |
| 2020 | $86.68 Million | $39.52K | -$3.36 Million | 2193.49x | N/A |
| 2021 | $189.12 Million | $83.68K | -$5.71 Million | 2259.96x | N/A |
| 2022 | $98.50 Million | $215.81K | -$4.88 Million | 456.41x | N/A |
| 2023 | $18.91 Million | $413.19K | -$4.50 Million | 45.77x | N/A |
| 2024 | $15.76 Million | $225.49K | -$3.40 Million | 69.89x | N/A |
Competitor Companies of HMD by Market Capitalization
Companies near Heramed Ltd in the global market cap rankings as of May 3, 2026.
Key companies related to Heramed Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Heramed Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Heramed Ltd's market cap moved from $126.08 Million to $ 38.61 Million, with a yearly change of -16.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$38.61 Million | +36.11% |
| 2025 | AU$28.37 Million | +80.00% |
| 2024 | AU$15.76 Million | -16.67% |
| 2023 | AU$18.91 Million | -80.80% |
| 2022 | AU$98.50 Million | -47.92% |
| 2021 | AU$189.12 Million | +118.18% |
| 2020 | AU$86.68 Million | -31.25% |
| 2019 | AU$126.08 Million | 0.00% |
| 2018 | AU$126.08 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Heramed Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.61 Million USD |
| MoneyControl | $38.61 Million USD |
| MarketWatch | $38.61 Million USD |
| marketcap.company | $38.61 Million USD |
| Reuters | $38.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Heramed Ltd
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more